SEC Form 13F
| Report period | 2026-06-30 |
|---|---|
| Publicly available | 2026-08-15 |
| Reported value | $4,160,526,316 |
| Positions | 54 |
| Issuer | Ticker | Class | Reported value | Reported amount |
|---|---|---|---|---|
| ABIVAX SA AMERICAN DEPOSITARY SHARES | ABVX | COMM | $800,603,959 | 6,007,834 |
| TANGO THERAPEUTICS INC | TNGX | COMM | $283,878,343 | 9,081,201 |
| CG ONCOLOGY INC | CGON | COMM | $260,768,136 | 3,670,206 |
| COGENT BIOSCIENCES INC | COGT | COMM | $187,866,673 | 4,854,436 |
| IMMUNOVANT INC | IMVT | COMM | $171,766,278 | 4,457,988 |
| SPYRE THERAPEUTICS INC | SYRE | COMM | $168,733,670 | 1,900,582 |
| DIANTHUS THERAPEUTICS INC | DNTH | COMM | $163,437,308 | 1,676,624 |
| MIRUM PHARMACEUTICALS INC | MIRM | COMM | $124,334,076 | 1,062,049 |
| ZAI LAB LTD-ADR | ZLAB | ADRS | $116,614,913 | 6,137,627 |
| AMYLYX PHARMACEUTICALS INC | AMLX | COMM | $112,138,864 | 6,243,812 |
Public filing evidence only. NexusTrade's simulated follower strategies are hypothetical, modeled results — not live trading returns and not investment advice.